← Back to Search

1 for Prostate Cancer

Phase 2
Waitlist Available
Led By Allan J Pantuck, MD
Research Sponsored by Roll International Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
No Placebo-Only Group

Summary

This trial tests whether pomegranate extract can delay prostate cancer progression & prolong the time between treatments for male patients who progressed during placebo treatment.

Eligible Conditions
  • Prostate Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Intervention 1

Find a Location

Who is running the clinical trial?

Roll International CorporationLead Sponsor
3 Previous Clinical Trials
767 Total Patients Enrolled
2 Trials studying Prostate Cancer
383 Patients Enrolled for Prostate Cancer
Allan J Pantuck, MDPrincipal InvestigatorUniversity of California, Los Angeles
2 Previous Clinical Trials
225 Total Patients Enrolled
2 Trials studying Prostate Cancer
225 Patients Enrolled for Prostate Cancer
Arie S Belldegrun, MDPrincipal InvestigatorUniversity of California, Los Angeles
1 Previous Clinical Trials
200 Total Patients Enrolled
1 Trials studying Prostate Cancer
200 Patients Enrolled for Prostate Cancer
~2 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top